Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuronal damage in brain inflammation.

Orhan Aktas1, Oliver Ullrich, Carmen Infante-Duarte

  • 1Cecilie Vogt Clinic for Molecular Neurology and Cell Biology and Neurobiology, Charité-Universitätsmedizin Berlin, 10098 Berlin, Germany. frauke.zipp@charite.de

Archives of Neurology
|February 14, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex-specific analysis of early disease course and treatment in a German multiple sclerosis cohort.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Gravity as a Boundary Condition for the Evolution of Three-Dimensional Multicellularity.

Life (Basel, Switzerland)·2026
Same author

Treatment approaches to patients with multiple sclerosis and coexisting psoriasis - A longitudinal multicenter observational cohort study.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same author

EPR-based Assessment of Gadolinium-based Contrast Agent Retention and Gadolinium Transchelation in Inflamed Murine Brain.

Investigative radiology·2026
Same author

CSF Proteins Associated With Neuroaxonal Damage in Early Active Multiple Sclerosis.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Neurons differentially upregulate type 2 immune cytokines and interleukin-4 receptor subtypes during neuroinflammation.

Acta neuropathologica communications·2026
Same journal

Incorrect Table Entries and Word.

Archives of neurology·2016
Same journal

IDEAL for CCSVI Research-Reply.

Archives of neurology·2013
Same journal

Atlas of Inherited Metabolic Diseases, 3rd ed.

Archives of neurology·2013
Same journal

Error in byline: in heterogeneity of coenzyme q10 deficiency: patient study and literature review.

Archives of neurology·2013
Same journal

This month in archives of neurology.

Archives of neurology·2013
Same journal

About this journal.

Archives of neurology·2013
See all related articles

Neuroinflammation causes neuronal damage in both classic inflammatory and non-inflammatory brain diseases. Targeting inflammation may improve outcomes for conditions like Alzheimer's, Parkinson's, and stroke.

Area of Science:

  • Neuroscience
  • Immunology
  • Neuropathology

Background:

  • Traditional views of brain diseases are challenged by new findings of neuronal damage.
  • Neuroinflammation is implicated in both classic neuroinflammatory and non-inflammatory neurological disorders.
  • Diseases like multiple sclerosis, meningitis, Alzheimer's, Parkinson's, and stroke exhibit inflammatory components.

Purpose of the Study:

  • To review the evidence for inflammatory neuronal damage in various brain diseases.
  • To discuss the clinical impact of neuroinflammation.
  • To explore therapeutic strategies targeting neuroinflammation.

Main Methods:

  • Literature review of recent studies and clinical trials.
  • Analysis of evidence from animal models and human epidemiological data.

Related Experiment Videos

  • Synthesis of findings on immune cell invasion, blood-brain barrier disruption, and cerebrospinal fluid changes.

    • Main Results:

    • Neuronal damage occurs in classic neuroinflammatory diseases (e.g., multiple sclerosis) with distinct inflammatory patterns.
    • Subtle inflammatory patterns are observed in non-inflammatory neurodegenerative diseases (e.g., Alzheimer's, Parkinson's, stroke).
    • Evidence suggests benefits of immunomodulatory therapies for non-inflammatory brain diseases.

    Conclusions:

    • Directly protecting neurons and axons is crucial for neuroinflammatory diseases.
    • Immunomodulatory therapies show promise for non-inflammatory brain diseases.
    • Understanding neuroinflammation's role is key to improving patient outcomes across a spectrum of neurological conditions.